Navidea Biopharmaceuticals, Inc. Press Releases

NAVB 
$0.8369
*  
0.0032
0.38%
Get NAVB Alerts
*Delayed - data as of May 27, 2016  -  Find a broker to begin trading NAVB now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing

$1.8 Million Fast-Track NIH SBIR Grant for Manocept™ Immunotherapeutics Evaluation in Kaposi’s Sarcoma Awarded to Navidea
5/26/2016 12:15:00 PM - Business Wire
▲3.32 % Price Change since this news event. The Volume Ratio is 1.08.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Provides Financing Update
5/23/2016 6:55:00 AM - Business Wire
▼-3.80 % Price Change since this news event. The Volume Ratio is 1.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Reports First Quarter 2016 Financial Results
5/17/2016 7:00:00 AM - Business Wire
▼-4.90 % Price Change since this news event. The Volume Ratio is 1.2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Biopharmaceuticals to Announce First Quarter 2016 Financial Results on May 17, 2016
5/10/2016 4:30:00 PM - Business Wire
▼-23.92 % Price Change since this news event. The Volume Ratio is 1.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea and Macrophage Therapeutics to Provide Development Program Update
5/3/2016 7:00:00 AM - Business Wire
▼-44.21 % Price Change since this news event. The Volume Ratio is 1.67.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Appoints Jed Latkin as Interim Chief Operating Officer
4/26/2016 5:00:00 PM - Business Wire
▼-39.36 % Price Change since this news event. The Volume Ratio is 1.01.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea and Macrophage Therapeutics to Provide Business Update
4/15/2016 7:00:00 AM - Business Wire
▼-20.30 % Price Change since this news event. The Volume Ratio is 5.54.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Updates Clinical Development Plan for Diagnostic Use of Lymphoseek® IV in Rheumatoid Arthritis
4/4/2016 7:00:00 AM - Business Wire
▼-17.14 % Price Change since this news event. The Volume Ratio is 3.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Announces Fourth Quarter and Full Year 2015 Results
3/23/2016 6:30:00 AM - Business Wire
▼-11.91 % Price Change since this news event. The Volume Ratio is 0.99.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Biopharmaceuticals to Announce Fourth Quarter and Full Year 2015 Results on March 23, 2016
3/21/2016 6:30:00 PM - Business Wire
▼-13.72 % Price Change since this news event. The Volume Ratio is 0.39.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Biopharmaceuticals Announces Delay in Filing of Form 10-K
3/14/2016 9:08:00 PM - Business Wire
▼-9.03 % Price Change since this news event. The Volume Ratio is 1.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea and Platinum Enter Into Agreement Reaffirming Loan Obligations and Agreeing to Standstill Provisions
3/14/2016 8:45:00 PM - Business Wire
▼-9.03 % Price Change since this news event. The Volume Ratio is 1.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Immunotherapeutic Potential of Manocept™ Platform Reviewed in the Journal Nuclear Medicine and Biology
3/10/2016 7:00:00 AM - Business Wire
▼-9.03 % Price Change since this news event. The Volume Ratio is 1.02.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day